Impact of Respiratory Rehabilitation on Quality of Life, Measures by the SF-36 Score, in Patients With Hyperventilation Syndrome: Crossover, Prospective and Randomized Study
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 44
- Locations
- 1
- Primary Endpoint
- Incidence of respiratory rehabilitation on Quality of life
Study Overview
Brief Summary
The hyperventilation syndrome is a quite frequent pathology, affecting up to 10% of the general population and 40% of the asthmatic population. Its physiopathology is still badly known and even if it is a benign affection, its associated comorbidities and symptomatology greatly decrease the patients' quality of life. Yet, no medicinal treatments have been proved useful, but prescribers noticed improvements after physiotherapy. Given that the physiotherapy impact on hyperventilation syndrome is not well described in the literature, this study aims to scientifically ascertain physiotherapy benefits on quality of life and symptomatology in hyperventilation syndrome-suffering patients.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Crossover
- Primary Purpose
- Supportive Care
- Masking
- Single (Outcomes Assessor)
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Positive hyperventilation syndrome diagnosis
- •Having a social security insurance
- •Being at least 18 years old
- •Having given their written consent
Exclusion Criteria
- •Being put under guardianship or curatorship
- •Having seen a physiotherapist for a respiratory rehabilitation in the last three months
- •Suffering from a chronic and degenerative pathology (chronic obstructive pulmonary disease, Parkinson's disease, idiopathic fibrosis, …)
- •Not being able to receive the respiratory rehabilitation from our care providers
- •Already having received a rehabilitation for hyperventilation syndrome
- •Not speaking French or not being unable to complete the questionnaires
Arms & Interventions
Control group
Group 1 (Control Group) will not immediately receive respiratory rehabilitation but between the 2nd and 4th months postdiagnosis.
Intervention: Respiratory rehabilitation (Other)
Intervention group
Group 2 (Intervention Group) will immediately receive rehabilitation between the diagnosis and the 2nd month postdiagnosis.
Intervention: Respiratory rehabilitation (Other)
Outcomes
Primary Outcomes
Incidence of respiratory rehabilitation on Quality of life
Time Frame: Month 4
Quality of life will be evaluated with the SF-36 score
Incidence of respiratory rehabilitation on Quality of life
Time Frame: Day 0
Quality of life will be evaluated with the SF-36 score
Incidence of respiratory rehabilitation on Quality of life
Time Frame: Month 2
Quality of life will be evaluated with the SF-36 score
Secondary Outcomes
- Change in symptomatology(Month 4)
- Change in symptomatology(Day 0)
- Change in symptomatology(Month 2)